Therapy Areas: Autoimmune
26 March 2024 - Pharmaceutical company Moderna Inc (NASDAQ: MRNA) announced on Tuesday that it has achieved successful Phase 3 trial results for mRNA-1283, its next-generation COVID-19 vaccine. Compar...
26 March 2024 - Immunology company argenx SE (Euronext Brussels:ARGX) (Nasdaq:ARGX) announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved VYVGART (efgartigi...
25 March 2024 - Science-led biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Monday that Ultomiris, a long-acting C5 complement inhibitor, has gained FDA appr...
8 March 2024 - Biotechnology company Thermo Fisher Scientific Inc. (NYSE:TMO) has unveiled its latest CorEvitas syndicated clinical registry for Generalized Pustular Psoriasis (GPP), addressing the ne...
20 February 2024 - Clinical stage biotech firm Chemomab Therapeutics Ltd (Nasdaq: CMMB) announced on Tuesday that it has been granted new patents for CM-101, its pioneering monoclonal antibody address...
20 February 2024 - Immunology company argenx SE (Euronext Brussels:ARGX) (Nasdaq:ARGX) reported on Tuesday that the US Food and Drug Administration (FDA) has accepted for priority review a supplementa...